Ensuring. Viral Safety of Viral Vaccines and Vectors

被引：0
|
作者：
Boumlic, Anissa [1 ]
Wisher, Martin [2 ]
Asher, Damon [3 ]
Pattnaik, Priyabrata [4 ]
机构：
[1] MilliporeSigma, EMEA Vaccine & Viral Therapies, Burlington, MA 01803 USA
[2] MilliporeSigma, Regulatory Affairs BioReliance, Burlington, MA USA
[3] MilliporeSigma, Amer Vaccine & Viral Therapies, Burlington, MA USA
[4] MilliporeSigma, Biol Operat Asia Pacific, Burlington, MA USA
来源：
BIOPHARM INTERNATIONAL | 2018年 / 31卷 / 09期
关键词：
HIGH-TEMPERATURE; INACTIVATION; VIRUS; IDENTIFICATION; CONTAMINATION; CLEARANCE;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：36 / 42
页数：7
相关论文
共 50 条
  • [31] VIRAL VACCINES
    KIT, M
    KIT, S
    MEDICAL CLINICS OF NORTH AMERICA, 1983, 67 (05) : 1129 - 1145
  • [32] Evidence for the In Vivo Safety of Insulated Foamy Viral Vectors
    Browning, Diana L.
    Everson, Elizabeth M.
    Leap, David J.
    Hocum, Jonah D.
    Wang, Hao
    Stamatoyannopoulos, George
    Trobridge, Grant D.
    MOLECULAR THERAPY, 2017, 25 (05) : 211 - 211
  • [33] Evidence for the in vivo safety of insulated foamy viral vectors
    D L Browning
    E M Everson
    D J Leap
    J D Hocum
    H Wang
    G Stamatoyannopoulos
    G D Trobridge
    Gene Therapy, 2017, 24 : 187 - 198
  • [34] Evidence for the in vivo safety of insulated foamy viral vectors
    Browning, D. L.
    Everson, E. M.
    Leap, D. J.
    Hocum, J. D.
    Wang, H.
    Stamatoyannopoulos, G.
    Trobridge, G. D.
    GENE THERAPY, 2017, 24 (03) : 187 - 198
  • [35] Improving the safety of viral DNA vaccines: development of vectors containing both 5′ and 3′ homologous regulatory sequences from non-viral origin
    A. Martinez-Lopez
    P. Encinas
    P. García-Valtanen
    E. Gomez-Casado
    J. M. Coll
    A. Estepa
    Applied Microbiology and Biotechnology, 2013, 97 : 3007 - 3016
  • [36] Improving the safety of viral DNA vaccines: Development of vectors containing both 5′ and 3′ homologous regulatory sequences from non-viral origin
    Martinez-Lopez, A.
    Encinas, P.
    García-Valtanen, P.
    Gomez-Casado, E.
    Coll, J.M.
    Estepa, A.
    Applied Microbiology and Biotechnology, 2013, 97 (07): : 3007 - 3016
  • [37] Improving the safety of viral DNA vaccines: development of vectors containing both 5′ and 3′ homologous regulatory sequences from non-viral origin
    Martinez-Lopez, A.
    Encinas, P.
    Garcia-Valtanen, P.
    Gomez-Casado, E.
    Coll, J. M.
    Estepa, A.
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2013, 97 (07) : 3007 - 3016
  • [38] SAFETY TEST OF TISSUE-CULTURE VIRAL VACCINES
    DOBROTVORTSEVA, VG
    MILOVIDOVA, NI
    VOPROSY VIRUSOLOGII, 1981, (02) : 132 - 136
  • [39] Viral safety and extraneous agents testing for veterinary vaccines
    Dodet, Betty
    Hesselink, Wim
    Jungbaeck, Carmen
    Lechenet, Jacques
    Pastoret, Paul-Pierre
    Vannier, Philippe
    Vicari, Marissa
    BIOLOGICALS, 2010, 38 (03) : 326 - 331
  • [40] CONTEMPORARY PROBLEMS IN REGULATING POTENCY AND SAFETY OF VIRAL VACCINES
    MURRAY, R
    BOLETIN DE LA OFICINA SANITARIA PANAMERICANA, 1968, 65 (05): : 434 - &
12345